Ekso Bionics Holdings, Inc. (EKSO)

NCM – Real Time Price. Currency in USD

11.80

+0.15 (1.29%)

At close: May 15, 2026, 4:00 PM EDT

06.05.2026

ChronoScale Appoints Cenly Chen as Chief Executive Officer to Lead Next Phase of AI Compute Growth

DALLAS, May 06, 2026 (GLOBE NEWSWIRE) -- ChronoScale Corporation (NASDAQ: CHRN), an accelerated compute platform purpose-built to support demanding artificial intelligence workloads, today announced the appointment of Cenly Chen as Chief Executive Officer and a member of the Company's Board of Directors.

21.01.2026

Ekso Bionics Prices $5.852 million Private Placement

SAN RAFAEL, Calif., Jan. 21, 2026 (GLOBE NEWSWIRE) -- Ekso Bionics Holdings, Inc. (the “Company”) (Nasdaq: EKSO), a leading developer of exoskeletons for medical and industrial use, today announced that on January 20, 2026 it entered into securities purchase agreements with certain institutional and accredited investors for the purchase and sale of an aggregate of 5,852 shares of the Company's Series B Preferred Stock (the “Preferred Stock”) and warrants (the “Warrants”) to purchase up to an aggregate of 355,960 shares of common stock of the Company in a private placement transaction (the “Private Placement”).

05.01.2026

$HAREHOLDER ALERT: The M&A Class Action Firm Announces An Investigation of EKSO Bionics Holdings, Inc. (NASDAQ: EKSO)

NEW YORK, Jan. 5, 2026 /PRNewswire/ -- Class Action Attorney Juan Monteverde with Monteverde & Associates PC (the "M&A Class Action Firm"), has recovered millions of dollars for shareholders and is recognized as a Top 50 Firm in the 2024 ISS Securities Class Action Services Report. The firm is headquartered at the Empire State Building in New York City and is investigating EKSO Bionics Holdings, Inc. (NASDAQ: EKSO ) related to its merge with Applied Digital Cloud.

30.12.2025

EKSO Stock Alert: Halper Sadeh LLC is Investigating Whether the Merger of EKSO Bionics Holdings, Inc. Is Fair to Shareholders

NEW YORK--(BUSINESS WIRE)--Halper Sadeh LLC, an investor rights law firm, is investigating whether the merger of EKSO Bionics Holdings, Inc. (NASDAQ: EKSO) and Applied Digital Cloud is fair to EKSO shareholders. Halper Sadeh encourages EKSO shareholders to click here to learn more about their legal rights and options or contact Daniel Sadeh or Zachary Halper at (212) 763-0060 or [email protected] or [email protected]. The investigation concerns whether EKSO and its board violated the.

29.12.2025

Applied Digital to Spin Out Cloud Business, Proposes Business Combination with EKSO to Launch ChronoScale

DALLAS, Dec. 29, 2025 (GLOBE NEWSWIRE) -- Applied Digital (NASDAQ: APLD), a designer, builder, and operator of high-performance, sustainably engineered data centers and colocation services for artificial intelligence, cloud, networking and blockchain workloads, and EKSO Bionics Holdings, Inc. (Nasdaq: EKSO) (“EKSO”) announced today that Applied Digital and EKSO entered into a non-binding term sheet for a proposed business combination of Applied Digital's cloud computing business, Applied Digital Cloud, with EKSO, which, once closed, will go forward as ChronoScale Corporation, an accelerated compute platform purpose-built to support artificial intelligence (“AI”) workloads (the “Proposed Transaction”). As enterprise and AI-native demand for GPU-accelerated cloud infrastructure continues to grow rapidly, the Proposed Transaction is intended to create a focused platform designed to deliver high-performance compute at scale in a capacity-constrained market.

04.12.2025

Ekso Bionics Inks Agreement to Become the Exclusive U.S. Distributor of MediTouch's Groundbreaking BalanceTutor™ Rehabilitation System

SAN RAFAEL, Calif. and TNUVOT, Israel, Dec. 04, 2025 (GLOBE NEWSWIRE) -- Ekso Bionics Holdings, Inc. (Nasdaq: EKSO) (“Ekso Bionics” or the “Company”), an industry leader in exoskeleton technology for medical and industrial use, today announced that it has entered into an agreement with Israel-based MediTouch Inc. (“MediTouch”) to become the exclusive authorized sales agent and distributor of MediTouch's BalanceTutor™ rehabilitation system in the United States.

21.11.2025

Ekso Bionics (EKSO) Upgraded to Buy: Here's Why

Ekso Bionics (EKSO) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.

Videos

No Data

There is no data to display

Press releases

06.05.2026

ChronoScale Appoints Cenly Chen as Chief Executive Officer to Lead Next Phase of AI Compute Growth

21.01.2026

Ekso Bionics Prices $5.852 million Private Placement

05.01.2026

$HAREHOLDER ALERT: The M&A Class Action Firm Announces An Investigation of EKSO Bionics Holdings, Inc. (NASDAQ: EKSO)

30.12.2025

Ekso Bionics Holdings, Inc. (EKSO)

Get all premium features to the best stock analysis tool

Finranks

Company

Contact us

Follow us

Ekso Bionics Holdings, Inc. (EKSO)

ChronoScale Appoints Cenly Chen as Chief Executive Officer to Lead Next Phase of AI Compute Growth

Ekso Bionics Prices $5.852 million Private Placement

$HAREHOLDER ALERT: The M&A Class Action Firm Announces An Investigation of EKSO Bionics Holdings, Inc. (NASDAQ: EKSO)

EKSO Stock Alert: Halper Sadeh LLC is Investigating Whether the Merger of EKSO Bionics Holdings, Inc. Is Fair to Shareholders

Applied Digital to Spin Out Cloud Business, Proposes Business Combination with EKSO to Launch ChronoScale

Ekso Bionics Inks Agreement to Become the Exclusive U.S. Distributor of MediTouch's Groundbreaking BalanceTutor™ Rehabilitation System

Ekso Bionics (EKSO) Upgraded to Buy: Here's Why

Videos

No Data

Press releases

ChronoScale Appoints Cenly Chen as Chief Executive Officer to Lead Next Phase of AI Compute Growth

Ekso Bionics Prices $5.852 million Private Placement

$HAREHOLDER ALERT: The M&A Class Action Firm Announces An Investigation of EKSO Bionics Holdings, Inc. (NASDAQ: EKSO)

EKSO Stock Alert: Halper Sadeh LLC is Investigating Whether the Merger of EKSO Bionics Holdings, Inc. Is Fair to Shareholders

ChronoScale Appoints Cenly Chen as Chief Executive Officer to Lead Next Phase of AI Compute Growth

Ekso Bionics Prices $5.852 million Private Placement

$HAREHOLDER ALERT: The M&A Class Action Firm Announces An Investigation of EKSO Bionics Holdings, Inc. (NASDAQ: EKSO)

EKSO Stock Alert: Halper Sadeh LLC is Investigating Whether the Merger of EKSO Bionics Holdings, Inc. Is Fair to Shareholders

Applied Digital to Spin Out Cloud Business, Proposes Business Combination with EKSO to Launch ChronoScale

Ekso Bionics Inks Agreement to Become the Exclusive U.S. Distributor of MediTouch's Groundbreaking BalanceTutor™ Rehabilitation System

Ekso Bionics (EKSO) Upgraded to Buy: Here's Why

Videos

No Data

Press releases

ChronoScale Appoints Cenly Chen as Chief Executive Officer to Lead Next Phase of AI Compute Growth

Ekso Bionics Prices $5.852 million Private Placement

$HAREHOLDER ALERT: The M&A Class Action Firm Announces An Investigation of EKSO Bionics Holdings, Inc. (NASDAQ: EKSO)

EKSO Stock Alert: Halper Sadeh LLC is Investigating Whether the Merger of EKSO Bionics Holdings, Inc. Is Fair to Shareholders

Search stocks

Ekso Bionics Holdings, Inc. (EKSO)

Get all premium features to the best stock analysis tool

Finranks

Company

Contact us

Follow us

Ekso Bionics Holdings, Inc. (EKSO)

ChronoScale Appoints Cenly Chen as Chief Executive Officer to Lead Next Phase of AI Compute Growth

Ekso Bionics Prices $5.852 million Private Placement

$HAREHOLDER ALERT: The M&A Class Action Firm Announces An Investigation of EKSO Bionics Holdings, Inc. (NASDAQ: EKSO)

EKSO Stock Alert: Halper Sadeh LLC is Investigating Whether the Merger of EKSO Bionics Holdings, Inc. Is Fair to Shareholders

Applied Digital to Spin Out Cloud Business, Proposes Business Combination with EKSO to Launch ChronoScale

Ekso Bionics Inks Agreement to Become the Exclusive U.S. Distributor of MediTouch's Groundbreaking BalanceTutor™ Rehabilitation System

Ekso Bionics (EKSO) Upgraded to Buy: Here's Why

Videos

No Data

Press releases

ChronoScale Appoints Cenly Chen as Chief Executive Officer to Lead Next Phase of AI Compute Growth

Ekso Bionics Prices $5.852 million Private Placement

$HAREHOLDER ALERT: The M&A Class Action Firm Announces An Investigation of EKSO Bionics Holdings, Inc. (NASDAQ: EKSO)

EKSO Stock Alert: Halper Sadeh LLC is Investigating Whether the Merger of EKSO Bionics Holdings, Inc. Is Fair to Shareholders

ChronoScale Appoints Cenly Chen as Chief Executive Officer to Lead Next Phase of AI Compute Growth

Ekso Bionics Prices $5.852 million Private Placement

$HAREHOLDER ALERT: The M&A Class Action Firm Announces An Investigation of EKSO Bionics Holdings, Inc. (NASDAQ: EKSO)

EKSO Stock Alert: Halper Sadeh LLC is Investigating Whether the Merger of EKSO Bionics Holdings, Inc. Is Fair to Shareholders

Applied Digital to Spin Out Cloud Business, Proposes Business Combination with EKSO to Launch ChronoScale

Ekso Bionics Inks Agreement to Become the Exclusive U.S. Distributor of MediTouch's Groundbreaking BalanceTutor™ Rehabilitation System

Ekso Bionics (EKSO) Upgraded to Buy: Here's Why

Videos

No Data

Press releases

ChronoScale Appoints Cenly Chen as Chief Executive Officer to Lead Next Phase of AI Compute Growth

Ekso Bionics Prices $5.852 million Private Placement

$HAREHOLDER ALERT: The M&A Class Action Firm Announces An Investigation of EKSO Bionics Holdings, Inc. (NASDAQ: EKSO)

EKSO Stock Alert: Halper Sadeh LLC is Investigating Whether the Merger of EKSO Bionics Holdings, Inc. Is Fair to Shareholders